Navigation Links
Nucletron Announces Management Buy-Out to More Effectively Meet the Demands of Its Customers and the Radiation Therapy Community

Newly Independent Radiation Oncology Company Emerges as Industry Leader

with Distinct Focus on Partnership, Innovation and Integration

VEENENDAAL, The Netherlands, Sept. 13 /PRNewswire/ -- Nucletron announced today the successful management buy-out from Delft Instruments, creating an independent company fully dedicated to radiation oncology. Since its inception in 1974, Nucletron has operated several entities in the field of radiation oncology throughout the world. The consolidation of the various entities into one, focused company further establishes Nucletron in a leadership role in this rapidly changing field. Collaborative partnerships, pioneering research and development of advanced technological innovations will enable Nucletron to more effectively deliver cancer treatment solutions globally and set the company apart within the industry.

"The creation of an independent Nucletron is the result of the company's success in the past two years," said David Imperiali, chief executive officer of Nucletron. "Nucletron has a strong tradition of innovation in radiotherapy, and the breadth of our capability positions the company well to continue to make significant contributions to the treatment of cancer."

The previous company, under Delft Instruments, was created in 1994 by merging Nucletron, the global leader in brachytherapy solutions, with the Oldelft Simulix(TM) brand of radiation therapy simulation and imaging technology. Additionally, in 2003, Nucletron integrated the Helax and Theratronics treatment planning and management solutions, from MDS Nordion, into its portfolio to create Oncentra(R) MasterPlan(TM) and Oncentra(R) Information Management.

"Nucletron's ability to restructure itself, anticipate needs, and incorporate new state-of-the-art products and services into our solutions suite gives us the ability to create strong and long-lasting relationships with our customers and partners," said Jeroen Cammeraat, chief operating officer of Nucletron. "The new corporate structure gives us the flexibility and agility to continue to develop world-class solutions for our customers and partners, focused on improving patient care."

With more than 10 percent of its revenues invested in research and development, Nucletron continuously seeks improvement of its existing product range and creation of new treatment options that improve patients' quality of care through curative and palliative treatment. The company's continued efforts in R&D, both in-house and through partnerships with leading academic institutions, have resulted in a strong and unique IP base.

Headquartered in The Netherlands, Nucletron delivers customized solutions to more than 3,000 institutions in more than 120 countries, equating to global sales of euro 120 million ($160 million), with operating profit levels that rank in the upper quartile of the industry. Worldwide, Nucletron has offices in 16 countries, including a production and R&D facility in The Netherlands, R&D centers in Uppsala, Sweden and Oslo, Norway and sales, marketing, service and support operations in Europe, Asia, Australia and North America.

The supervisory board of Nucletron will be chaired by Rob Westerhof, who has held senior positions in Asia and in the USA for Philips Medical Systems and Philips Electronics. Commenting on the spin-off, Westerhof stated, "I am excited to join Nucletron's supervisory board. Being involved in the medical business for more than 15 years in various positions throughout the world, I trust that I can make a contribution. Nucletron represents a strong brand in the world of oncology and related areas, and there are excellent opportunities for expanding our market share. I am looking forward to working with the new management team and further strengthening Nucletron."

About Nucletron

Nucletron is a knowledge-based leader in Radiation Oncology, working with clinical teams to realize innovative solutions that improve patient care. Nucletron strives to offer the best possible choice of radiation modalities through integrated products, software and services. Critical to the Nucletron philosophy is the establishment of close working relationships with individual clinical teams - reconfiguring traditional boundaries between customer and solution provider. Many Nucletron employees have clinical experience delivering oncology care, providing an in-depth understanding of the complex needs of clinicians. The investors in the independent Nucletron company include AlpInvest Partners, Advent International, the Nucletron Management and Employees. For more information, visit

SOURCE Nucletron
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... ... 27th edition of USA Today in Atlanta, Dallas, New York, Minneapolis, South Florida, ... The digital component is distributed nationally, through a vast social media strategy and ...
(Date:11/27/2015)... ... November 27, 2015 , ... MPWH, the No.1 Herpes-only dating community in the world, ... Table 1-1 ). More than 3.7 billion people under the age of 50 – ... according to WHO's first global estimates of HSV-1 infection . , "The data shocks ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... of the well-respected Microsoft Dynamics SL User Group (MSDSLUG). Recognized as Microsoft’s official ... independent group of Microsoft Dynamics SL software users, partners, industry experts and representatives. ...
(Date:11/27/2015)... ... November 27, 2015 , ... The moment you stop improving ... only fulfilling the needs of advisers and clients but going above and beyond ... top-tier customer service. However, there's always room for improvement, which is why the ...
(Date:11/27/2015)... ... , ... CBD College is proud to announce that on November ... to its Diagnostic Medical Sonography program. CBD College is honored to join this very ... and universities in the state of California make the cut. CBD College is officially ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 /PRNewswire/ ... --> adds "Global ... and "Investigation Report on China Repaglinide ... 2021 forecasts data and information to ... . --> ...
(Date:11/25/2015)... DUBLIN , Nov. 25, 2015 /PRNewswire/ ... announced the addition of the "Global ... to their offering. --> ... "Global Brain Monitoring Devices Market 2015-2019" ... Research and Markets ( ) ...
(Date:11/25/2015)... 25, 2015 AAIPharma Services Corp./Cambridge Major ... at least $15.8  Million to expand its laboratories ... . The expansion will provide additional office ... growing demands of the pharmaceutical and biotechnology markets. ... will provide up to 40,000 square feet of ...
Breaking Medicine Technology: